FDA Monitoring for Facial Paralysis After COVID Vaccines

During phase 3 clinical trials of mRNA vaccines, more cases of facial paralysis occurred in the vaccine groups compared to the placebo group, leading the U.S. Food and Drug Administration to recommend monitoring vaccine recipients for facial paralysis.